As instrumental variables, amino acid variations in the model genes XRCC6 and PRKDC considerably affected apoptotic protein levels, macrophage markers, and macrophage secretion factors (Figure 5A), thereby altering lung cancer outcomes (Figure 5B). This evidence concerns the gene XRCC6 and lung cancer.